CPHD Receives FDA Clearance For Xpert Flu/RSV XC; SUPN Receives Issuance Of Fifth US Patent

CPHD announced it has received clearance from the U.S. FDA to market its Xpert®, SUPN, announced the issuance of a fifth patent (number 8,889,191) by the United States Patent and Trademark Office (USPTO), its novel once-daily extended-release topiramate product.